US Patent 7115739 Triazole compounds useful as protein kinase inhibitors

Patent 7115739 was granted and assigned to Vertex Pharmaceuticals on October, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Vertex Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7115739

Date of Patent

October 3, 2006

Patent Application Number

09953471

Date Filed

September 14, 2001

Patent Citations Received

‌

US Patent 11980633 Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors

‌

US Patent 11702401 Compounds and methods of use

Patent Primary Examiner

‌

Thomas C. McKenzie

Patent abstract

This invention describes novel triazole compounds of formula IX:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7115739 Triazole compounds useful as protein kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API